Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382600605> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4382600605 endingPage "7" @default.
- W4382600605 startingPage "6" @default.
- W4382600605 abstract "There has been a knowledge gap concerning the effect of anticoagulant treatment for recurrent pregnancy loss in women with hereditary thrombophilia. In the updated guideline from the European Society of Human Reproduction and Embryology on recurrent pregnancy loss from 2022, 1 ESHRE Recurrent Pregnancy Loss Guideline Development GroupRecurrent pregnancy loss: guideline of European Society of Human Reproduction and Embryology. https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Recurrent-pregnancy-lossDate: Feb 1, 2023 Date accessed: June 20, 2023 Google Scholar there is a conditional recommendation not to use low-molecular-weight heparin (LMWH), based on low certainty of evidence. This called for another trial, particularly as LMWH was still being prescribed by many clinicians. In The Lancet, Siobhan Quenby and colleagues presented the results of the ALIFE2 trial, an international collaborative effort to fill that knowledge gap. 2 Quenby S Booth K Hiller L et al. Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial. Lancet. 2023; (published online May 31.)https://doi.org/10.1016/S0140-6736(23)00693-1 Summary Full Text Full Text PDF PubMed Scopus (2) Google Scholar Recruitment of 326 women took 8·5 years to complete, a long time for a randomised controlled trial to run, and the investigators are to be commended for their persistence. Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trialLMWH did not result in higher livebirth rates in women who had two or more pregnancy losses and confirmed inherited thrombophilia. We do not advise use of LMWH in women with recurrent pregnancy loss and inherited thrombophilia, and we advise against screening for inherited thrombophilia in women with recurrent pregnancy loss. Full-Text PDF" @default.
- W4382600605 created "2023-06-30" @default.
- W4382600605 creator A5059767907 @default.
- W4382600605 creator A5063238305 @default.
- W4382600605 date "2023-07-01" @default.
- W4382600605 modified "2023-09-25" @default.
- W4382600605 title "Time to stop routine prescription of low-molecular-weight heparin to women with recurrent pregnancy loss and inherited thrombophilia" @default.
- W4382600605 cites W2015639441 @default.
- W4382600605 cites W2049598629 @default.
- W4382600605 cites W2118241673 @default.
- W4382600605 cites W2136152362 @default.
- W4382600605 cites W2292858884 @default.
- W4382600605 cites W2899822630 @default.
- W4382600605 cites W4285098083 @default.
- W4382600605 cites W4379015109 @default.
- W4382600605 doi "https://doi.org/10.1016/s0140-6736(23)01190-x" @default.
- W4382600605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37393104" @default.
- W4382600605 hasPublicationYear "2023" @default.
- W4382600605 type Work @default.
- W4382600605 citedByCount "0" @default.
- W4382600605 crossrefType "journal-article" @default.
- W4382600605 hasAuthorship W4382600605A5059767907 @default.
- W4382600605 hasAuthorship W4382600605A5063238305 @default.
- W4382600605 hasConcept C131872663 @default.
- W4382600605 hasConcept C141071460 @default.
- W4382600605 hasConcept C142724271 @default.
- W4382600605 hasConcept C187212893 @default.
- W4382600605 hasConcept C2776884760 @default.
- W4382600605 hasConcept C2777557582 @default.
- W4382600605 hasConcept C2779234561 @default.
- W4382600605 hasConcept C2779245376 @default.
- W4382600605 hasConcept C2780182762 @default.
- W4382600605 hasConcept C2780625311 @default.
- W4382600605 hasConcept C2780842393 @default.
- W4382600605 hasConcept C2780868729 @default.
- W4382600605 hasConcept C29456083 @default.
- W4382600605 hasConcept C54355233 @default.
- W4382600605 hasConcept C71924100 @default.
- W4382600605 hasConcept C86803240 @default.
- W4382600605 hasConceptScore W4382600605C131872663 @default.
- W4382600605 hasConceptScore W4382600605C141071460 @default.
- W4382600605 hasConceptScore W4382600605C142724271 @default.
- W4382600605 hasConceptScore W4382600605C187212893 @default.
- W4382600605 hasConceptScore W4382600605C2776884760 @default.
- W4382600605 hasConceptScore W4382600605C2777557582 @default.
- W4382600605 hasConceptScore W4382600605C2779234561 @default.
- W4382600605 hasConceptScore W4382600605C2779245376 @default.
- W4382600605 hasConceptScore W4382600605C2780182762 @default.
- W4382600605 hasConceptScore W4382600605C2780625311 @default.
- W4382600605 hasConceptScore W4382600605C2780842393 @default.
- W4382600605 hasConceptScore W4382600605C2780868729 @default.
- W4382600605 hasConceptScore W4382600605C29456083 @default.
- W4382600605 hasConceptScore W4382600605C54355233 @default.
- W4382600605 hasConceptScore W4382600605C71924100 @default.
- W4382600605 hasConceptScore W4382600605C86803240 @default.
- W4382600605 hasIssue "10395" @default.
- W4382600605 hasLocation W43826006051 @default.
- W4382600605 hasLocation W43826006052 @default.
- W4382600605 hasOpenAccess W4382600605 @default.
- W4382600605 hasPrimaryLocation W43826006051 @default.
- W4382600605 hasRelatedWork W1582935822 @default.
- W4382600605 hasRelatedWork W1596072820 @default.
- W4382600605 hasRelatedWork W2004860469 @default.
- W4382600605 hasRelatedWork W2077087361 @default.
- W4382600605 hasRelatedWork W2126945338 @default.
- W4382600605 hasRelatedWork W25593590 @default.
- W4382600605 hasRelatedWork W2594069839 @default.
- W4382600605 hasRelatedWork W2981815377 @default.
- W4382600605 hasRelatedWork W4319655794 @default.
- W4382600605 hasRelatedWork W4362616329 @default.
- W4382600605 hasVolume "402" @default.
- W4382600605 isParatext "false" @default.
- W4382600605 isRetracted "false" @default.
- W4382600605 workType "article" @default.